Latest pulmonary disease News

Awards to researchers in occupational and environmental medicine
Microrobots made of algae carry chemo directly to lung tumors, improving cancer treatment
Australians Living Longer, But In Need Of More Support
Five workplace cancer risk factors for tradies – Men’s Health Week
Mr José Luis Castro appointed as WHO Director-General Special Envoy for Chronic Respiratory Diseases
COVID-19 pandemic “a dress rehearsal” for climate change
WHO to host second global conference on air pollution and health
COVID-19 eliminated a decade of progress in global level of life expectancy
The bacteria in your mouth play an important role in your health – here are four diseases linked to your oral microbiome
Ground-breaking research ‘Unlocks spinal health for older Australians’
Exploring the effect of H2O2 eustress on individual cancer cells using hopping probe scanning ion conductance microscopy (HPICM)
AMA Calls Out Sick System On Chronic Conditions
AIHW data reinforces the need for targeted investment in rural health
Rollout Begins For Australian-first Pharmacy Pilot
Scientists grow human mini-lungs as animal alternative for nanomaterial safety testing
Preparing For Allergic Reaction
Locums and permanent GPs equally safe, study reassures patients
Early Start To Spring Allergies
Acquisition of Icosavax Completed
Research reveals gut’s crucial role in lung disease
Bushfires in Victoria: how to protect yourself if the air is smoky where you live
Healthy investment in better patient outcomes
Research to help people born preterm breathe easier
ResMed brings breath of life to millions in India
Death toll shows extreme air pollution events a growing urban threat
Australia’s first RSV (respiratory syncytial virus) vaccine AREXVY approved by TGA
$3.6m NHMRC funding fuels innovative ideas
New estimate doubles likely deaths from fungal disease globally
QIMR Berghofer engages AI partner to fast-track cancer drug discovery
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data
Even small amounts of physical activity could be valuable in late-stage lung cancer
Smoking is the leading cause of chronic obstructive pulmonary disease
Pivotal role of TLR7 protein revealed in lung disease
“Breathing is life”: Australia must clean up its cars to protect people against COPD
WHO updates guidelines on treatments for COVID-19
Climate change and noncommunicable diseases: connections
3 ways to prepare for bushfire season if you have asthma or another lung condition
Improve use of medicines and medical tests with $26 million in grants
Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA)
WHO launches groundbreaking air pollution training for health workers on International Day of Clean Air
Consumer and medical groups welcome start of 60-day scripts for patients
AstraZeneca data at ERS 2023 demonstrate leadership in transforming care across a broad respiratory portfolio of inhaled and biologic medicines
AstraZeneca demonstrates scientific leadership with compelling new data at ESC Congress 2023 on the interconnections across chronic diseases
Surviving lung cancer is just beginning
Australians living longer but dementia and Alzheimer’s a greater risk
Omega-3 fatty acids promising for maintaining lung health
Small islands agree bold plan of action on health and climate crises
MPs and Senators urged to support 60-day dispensing to save Australians money and time